Statement of Changes in Beneficial Ownership (4)

FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Caveney Brian J	2. Issuer Name and Ticker or Trading Symbol LABORATORY CORP OF AMERICA HOLDINGS [ LH ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) EVP, President of Diagnostics
(Last) (First) (Middle) 531 SOUTH SPRING STREET	3. Date of Earliest Transaction (MM/DD/YYYY) 2/12/2020
(Street) BURLINGTON, NC 27215 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	2/12/2020		M		233	A	⁽¹⁾	556.3903 ⁽²⁾	D
Common Stock	2/12/2020		F⁽³⁾		82	D	$187.51	474.3903 ⁽²⁾	D
Common Stock	2/12/2020		M		283	A	⁽¹⁾	757.3903 ⁽²⁾	D
Common Stock	2/12/2020		F⁽³⁾		86	D	$187.51	671.3903 ⁽²⁾	D
Common Stock	2/12/2020		M		2353	A	⁽¹⁾	3024.3903 ⁽²⁾	D
Common Stock	2/12/2020		F⁽³⁾		698	D	$187.51	2326.3903 ⁽²⁾	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	2/12/2020		M			233	⁽⁴⁾	⁽⁴⁾	Common Stock	233	$0	16824 ⁽⁵⁾	D
Restricted Stock Unit	⁽¹⁾	2/12/2020		M			283	⁽⁶⁾	⁽⁶⁾	Common Stock	283	$0	16541 ⁽⁵⁾	D
Restricted Stock Unit	⁽¹⁾	2/12/2020		M			2353	⁽⁶⁾	⁽⁶⁾	Common Stock	2353	$0	14188 ⁽⁵⁾	D

Explanation of Responses:
(1)	Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.
(2)	Amount includes 105.4961 shares acquired on June 28, 2019 and 66.8942 shares acquired on December 31, 2019 under the Laboratory Corporation of America Holdings 2016 Employee Stock Purchase Plan.
(3)	Stock withholding to satisfy tax withholding obligations.
(4)	The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2019.
(5)	This number reflects the aggregate number of Restricted Stock Units held by the reporting person.
(6)	The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Caveney Brian J 531 SOUTH SPRING STREET BURLINGTON, NC 27215			EVP, President of Diagnostics